Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer-Reference-Cited by-同舟云学术

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer

Published:2023-01-05 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wang Fulong¹,Lu Shixun²,Cao Di¹,Qian Juanjuan³,Li Cong¹,Zhang Rongxin¹,Wang Feng⁴,Wu Miaoqing¹,Liu Yifan¹,Pan Zhizhong¹,Wu Xiaojun¹,Lu Zhenhai¹,Ding Peirong¹,Li Liren¹,Lin Junzhong¹,Catteau Aurélie⁵,Galon Jérôme⁵⁶⁷⁸^ORCID,Chen Gong¹

Affiliation:

1. Department of Colorectal Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Hong Kong, China

2. Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Hong Kong, China

3. Department of Medicine, Genecast Biotechnology Co., Ltd, Beijing, China

4. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Hong Kong, China

5. Veracyte, Marseille, France

6. INSERM, Laboratory of Integrative Cancer Immunology, Paris, France

7. Equipe Labellisée Ligue Contre le Cancer, Paris, France

8. Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Paris, France

Funder

funding

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2161167